[3P] Depression and Bipolar Disorders

Fri. Jul 30, 2021 2:20 PM - 3:20 PM Poster & Exhibition (1F, No.2 Bldg., Exhibition Hall)

+Add all to schedule

[3P-132] Antidepressant-Responsive Anhedonia in Drosophila

〇Yuto Nishizuka¹, Masato Tsuji¹, Kazuo Emoto^1,2 (1.Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 2.International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo)

[3P-134] Oxytocin treatment improves dexamethasone-induced depression-like behavior by activating the hippocampal CREB-BDNF signaling pathway in female mice

〇Masayoshi Mori¹, Hiromi Shizunaga¹, Hiroyoshi Harada¹, Yuki Tajiri¹, Shunsuke Kawanabe¹, Toru Kuriyama¹, Yusuke Murata¹, Taichi Matsumoto², Kazuki Terada³, Kenji Ohe¹, Munechika Enjoji¹ (1.Dept Pharmacother, Fac Pharmaceuti Sci, Fukuoka Univ, Fukuoka, Japan, 2.Dept Drug Informatics, Fac Pharmaceuti Sci, Fukuoka Univ, Fukuoka, Japan, 3.Dept Pharmacother, Fac Pharmaceuti Sci, Himeji Dokkyo Univ, Hyogo, Japan)

[3P-136] Association between sensorimotor gating and cerebrospinal fluid inflammatory cytokine levels in patients with major depressive disorder: a pilot study

〇Junko Matsuo¹, shinsuke Hidese^1,2, Kotaro Hattori^1,3, Daimei Sasayama¹, Yuuki Yokota^1,3, Ryo Matsumura³, Ikki Ishida^1,2, Miho Ota¹, Hiroaki Hori¹, Yukihito Yomogida¹, Hiroshi Kunugi^1,2 (1.Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 2.Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan, 3.Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan)